Copyright
©2013 Baishideng Publishing Group Co.
World J Crit Care Med. Nov 4, 2013; 2(4): 48-55
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Figure 2 Macroscopic and histological findings of the retroperitoneal tissue.
A: Hydronephrosis in the left kidney in the non-therapy group (HE, × 40); B: A large amount of tumor tissues (arrowheads) was recognized on the retroperitoneum in the non-therapy group (HE, × 40); C: Mild hydronephrosis in the right kidney in the therapy group (HE, × 40); D: A small amount of tumor tissues (arrowheads) was recognized on the retroperitoneum in the therapy group (HE, × 40). HE staining, with low magnification, on the cut surface of retroperitoneal tissues in the non-therapy group and the therapy group.
- Citation: Aoyagi K, Kouhuji K, Miyagi M, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med 2013; 2(4): 48-55
- URL: https://www.wjgnet.com/2220-3141/full/v2/i4/48.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v2.i4.48